| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.036 | 7.750 | 4.488 | 4.201 | 975 | 1.835 | 5.336 |
| Total Income - EUR | - | - | - | 1.036 | 7.750 | 4.488 | 4.201 | 975 | 1.835 | 5.336 |
| Total Expenses - EUR | - | - | - | 184 | 242 | 1.327 | 1.288 | 341 | 50 | 2.318 |
| Gross Profit/Loss - EUR | - | - | - | 852 | 7.508 | 3.162 | 2.913 | 635 | 1.784 | 3.018 |
| Net Profit/Loss - EUR | - | - | - | 820 | 7.275 | 3.036 | 2.789 | 610 | 1.505 | 2.500 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Dr. Felixb Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 450 | 259 | 74 | 0 | 0 | 692 |
| Current Assets | - | - | - | 932 | 7.798 | 5.287 | 2.858 | 770 | 2.552 | 4.479 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 274 | 711 | 147 | 507 | 72 | 896 | 71 |
| Cash | - | - | - | 658 | 7.087 | 5.140 | 2.351 | 698 | 1.657 | 4.407 |
| Shareholders Funds | - | - | - | 857 | 8.116 | 5.467 | 2.838 | 659 | 2.161 | 4.649 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 75 | 132 | 79 | 95 | 112 | 391 | 521 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dr. Felixb Medical Srl